Epidemiology of Hepatitis C

• 75% of hemophiliacs treated with ᡂ,000 units of factor VIII concentrates are seropositive

• 85% of intravenous drug users (IVDA) are seropositive

• Prevalence of hepatitis C antibody in volunteer blood donors is < 1%.

Previous slide

Next slide

Back to first slide

View graphic version